Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Chronic lymphocytic leukaemia:

new diagnostic and therapeutic advances - Großformatiges Paperback. Klappenbroschur
BuchKartoniert, Paperback
76 Seiten
Englisch
Our Knowledge Publishingerschienen am12.04.2024
Chronic lymphocytic leukaemia is a lymphoproliferative syndrome that generally occurs in elderly patients. It is defined by a progressive accumulation of mature monoclonal B lymphocytes in the blood, marrow and secondary lymphoid organs. Diagnosis is based mainly on B hyperlymphocytosis > 5G/L persisting for more than three months, a blood smear and immunophenotyping of blood cells. Other tests, such as del 17 p +/- Tp 53, IgHV mutation status, CD 38, etc., are of interest in characterising predictive prognostic factors in order to better identify patients at risk of progression and choose the appropriate therapeutic strategy. This haemopathy generally has a good prognosis, but the course is very heterogeneous, with the majority of asymptomatic patients having a survival similar to that of healthy subjects of the same age and sex. On the other hand, some patients have a progressive disease, with an increase in adenopathies and worsening cytopenias, requiring specific treatment.mehr

Produkt

KlappentextChronic lymphocytic leukaemia is a lymphoproliferative syndrome that generally occurs in elderly patients. It is defined by a progressive accumulation of mature monoclonal B lymphocytes in the blood, marrow and secondary lymphoid organs. Diagnosis is based mainly on B hyperlymphocytosis > 5G/L persisting for more than three months, a blood smear and immunophenotyping of blood cells. Other tests, such as del 17 p +/- Tp 53, IgHV mutation status, CD 38, etc., are of interest in characterising predictive prognostic factors in order to better identify patients at risk of progression and choose the appropriate therapeutic strategy. This haemopathy generally has a good prognosis, but the course is very heterogeneous, with the majority of asymptomatic patients having a survival similar to that of healthy subjects of the same age and sex. On the other hand, some patients have a progressive disease, with an increase in adenopathies and worsening cytopenias, requiring specific treatment.
Details
ISBN/GTIN978-620-7-37818-0
ProduktartBuch
EinbandartKartoniert, Paperback
Erscheinungsjahr2024
Erscheinungsdatum12.04.2024
Seiten76 Seiten
SpracheEnglisch
Artikel-Nr.61530691

Autor